2015-05-11

Senior Scientist II, Antibody Drug Conjugate Chemistry


 
 AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 26,000 people worldwide and markets medicines in more than 170 countries.


The Medicinal Chemistry organization has an exciting opportunity available for a Senior Scientist t II or I (depending on experience) to conceive and execute organic synthetic chemistry research in the area of antibody drug conjugates (ADC’s).



Key Responsibilities:

    Design, synthesize and optimize novel linker technologies for ADC applications
    Design, synthesize and optimize novel small molecule drugs for ADC applications
    Maintain high levels of productivity in a laboratory setting
    Collaborate with core Biologics, Process Development and ADC Conjugation teams to expand ADC platform technologies at AbbVie


more :  https://abbvie.taleo.net/careersection/2/jobdetail.ftl?lang=en&job=58103&src=JB-11040